Browse Mechcatie, Elizabeth

1-100 out of 139 article(s) next next page

Title	Type	Date	Words
Panel backs second HPV vaccine for girls, women.		Oct 1, 2009	466
Gardasil gets nod from panel as genital wart Tx in boys, men.		Oct 1, 2009	587
Asenapine wins approval based on short-term data: sublingual antipsychotic adds to options.		Sep 1, 2009	748
Sublingual antipsychotic gets nod from FDA panel: asenapine safe, effective.		Aug 1, 2009	661
FDA panel deems atypicals safe for children, teens: three antipsychotics also 'effective.'.		Jul 1, 2009	976
Data on metabolic acidosis prompt alert on zonisamide.		Jul 1, 2009	270
List of illegal over-the-counter weight-loss products grows.		Jun 1, 2009	248
Cardiovascular, other safety data raise panel's concerns on sertindole.		May 1, 2009	635
Guidelines focus on opioids for chronic pain.		Mar 1, 2009	600
FDA clears device for resistant depression data analysis positive.		Nov 1, 2008	433
St. John's wort holds its own in meta-analysis.		Nov 1, 2008	873
Pediatric schizophrenia findings consistent.	Clinical report	Oct 1, 2008	1276
Simvastatin-amiodarone interaction prompts alert.		Sep 1, 2008	360
Panels discourage black box warning on AEDs; Antiepileptic drug patients should get medication guide explaining suicidality risk, members suggest.		Aug 1, 2008	1045
FDA considers changes to drug label pregnancy info.		Aug 1, 2008	483
CV safety studies needed for new diabetes drugs.		Aug 1, 2008	785
Duloxetine becomes the second drug approved for treatment of fibromyalgia.		Jul 1, 2008	541
Generic versions of ropinirole OK'd for restless legs syndrome.		Jul 1, 2008	176
Stress affects athletic injuries, recovery: physicians not immune to 'culture of risk,' which encourages athletes to keep playing despite pain.		May 1, 2008	803
Approval of aripiprazole might reassure parents.		Apr 1, 2008	717
Suicide rates among young men in U.K. show decline.		Mar 1, 2008	372
Revised modafinil label cites psychiatric risks.		Jan 1, 2008	569
Second atypical is approved for treating schizophrenia in teens.		Dec 1, 2007	649
Antipsychotic okayed as add-on for MDD.		Dec 1, 2007	341
Alert is issued on smoking cessation drug.		Dec 1, 2007	323
Study results on mercury exposure 'reassuring'.		Nov 1, 2007	560
New cardiac alert added to haloperidol label.		Oct 1, 2007	301
New diabetes guidelines stress lifestyle changes: endocrinology association task force emphasizes individualized treatment over a 'cookbook approach.'.		Sep 1, 2007	812
Rivastigmine patch approved for dementia.		Aug 1, 2007	721
Pregabalin is first drug approved for fibromyalgia.		Aug 1, 2007	601
Neurologic sequelae tied to gastric bypass surgery.		Aug 1, 2007	636
First transdermal drug OK'd for Parkinson's.		Jul 1, 2007	929
Data help prioritize drugs for treating epilepsy.	Clinical report	Jun 1, 2007	690
Provigil maker cited after promotion of unapproved 'fatigue' indication.		May 1, 2007	321
FDA calls for expanded warnings on antidepressants.		May 1, 2007	669
Sleep drug labels to address adverse effects.		Apr 1, 2007	721
Drugs sold on Internet found to contain haloperidol.	Brief article	Apr 1, 2007	265
FDA approves duloxetine for anxiety.		Mar 1, 2007	592
Postmarketing studies of VNS yielding no surprises so far.		Mar 1, 2007	742
FDA panel wants more data on TMS.		Feb 1, 2007	613
Panel backs expanding label on antidepressants.		Jan 1, 2007	994
Pramipexole approved for restless legs syndrome: dopamine agonists were already considered first-line treatment.		Jan 1, 2007	796
FDA issues warning on venlafaxine.		Dec 1, 2006	440
Donepezil approved for severe dementia Tx.		Nov 1, 2006	660
FDA advisory warns of serotonin syndrome.		Nov 1, 2006	337
Warning targets several Canadian drug Web sites.	Brief article	Nov 1, 2006	203
Quetiapine wins approval for bipolar depression.	Brief article	Nov 1, 2006	189
Transdermal postoperative pain control device approved.		Nov 1, 2006	401
Alert issued on low-dose aspirin + ibuprofen.		Oct 1, 2006	368
FDA releases advisory on treating pregnant women with depression.		Sep 1, 2006	362
FDA cites Stevens-Johnson in modafinil's ADHD rejection.		Sep 1, 2006	376
Obesity tied to higher risk of mood disorders.	Brief article	Aug 1, 2006	262
MAO inhibitor is approved for Parkinson's.		Aug 1, 2006	847
Once-a-day combination pill approved for HIV.		Aug 1, 2006	810
Antigen-specific multiple sclerosis therapy to be evaluated.	Clinical report	Aug 1, 2006	649
Bupropion wins approval for SAD.		Jul 1, 2006	541
Rivastigmine backed for Parkinson's dementia.		Jul 1, 2006	912
Tysabri is again available--with conditions.		Jul 1, 2006	607
FDA panel nixes black boxes for ADHD drugs: pediatric advisory unit favors use of highlights box on label for stronger warnings about adverse events.	Statistical data	May 1, 2006	1529
Panel favors strict limits on natalizumab's return.		May 1, 2006	1090
Patch approval: 'big moment' in psychopharm: resistant depression patients may benefit.		Apr 1, 2006	1203
Call for black box on ADHD drugs deemed premature: panel cited adverse cardiovascular events.		Mar 1, 2006	1401
Weight-loss drug orlistat backed for OTC status: an FDA advisory panel has recommended OTC approval of the drug, which reduces fat absorption.		Mar 1, 2006	1138
Panel supports ADHD drug patch with warning: methylphenidate sensitization a concern.		Jan 1, 2006	1055
FDA panel backs selegiline patch for depression.		Dec 1, 2005	1142
FDA panel blocks urine test for Alzheimer's: test detects neural thread protein, but it's unclear whether that is a valid biomarker of the disease.		Sep 1, 2005	1271
FDA approves two monitoring changes for clozapine patients.		Sep 1, 2005	787
FDA approves melatonin agonist for insomnia.		Sep 1, 2005	613
Drug combination for migraines deemed too risky for approval.		Sep 1, 2005	556
Drug approved for heart failure in black patients.		Aug 1, 2005	1311
Risperidone 'nonapprovable' for Alzheimer's psychosis and autism.	Brief Article	Jul 1, 2005	174
SSRI use tied to reports of neonatal withdrawal symptoms.		Jul 1, 2005	946
Rare demyelinating disorder tied to MS drug.		Jul 1, 2005	881
FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly unanimous support; vote was more divided on rofecoxib and valdecoxib.		Apr 1, 2005	1211
Synthetic marine snail toxin receives FDA approval as intrathecal analgesic.		Mar 1, 2005	438
FDA panel votes no on sex dysfunction patch: safety concerns prompt unanimous vote against indication for treating female sexual dysfunction.		Mar 1, 2005	1015
FDA approves new drug for postherpetic neuralgia.		Feb 1, 2005	398
FDA plans to strengthen Drug Safety program.		Jan 1, 2005	457
Rx mix-ups prompt Reminyl name change.	Brief Article	Jan 1, 2005	304
IBS drug approved for idiopathic constipation.		Jan 1, 2005	622
FDA approves extended-release hydromorphone.		Dec 1, 2004	627
Asthma drug's label gets hepatotoxicity warning.		Nov 1, 2004	331
FDA panels back black box warning on antidepressants: analysis of 24 pediatric trials showed an increased suicidality risk of 2%-3%.		Oct 1, 2004	1810
Ziprasidone approved for acute bipolar mania.		Sep 1, 2004	675
Alcohol abstinence drug wins FDA approval: acamprosate is thought to help alcohol-dependent patients who are not drinking at start of treatment.		Sep 1, 2004	723
Warnings appearing on antidepressant labels.		Aug 1, 2004	319
Eye problems not tied to in utero antidepressants.	Brief Article	Aug 1, 2004	271
Panel backs vagal nerve stimulator for depression: device deemed safe for recalcitrant cases.		Jul 1, 2004	1151
FDA panel backs SSRI lable change for pregnancy.		Jul 1, 2004	929
Wyeth fails to sway FDA on venlafaxine, kids.		Jul 1, 2004	614
Risk management program for IBS drug on track: alosetron was reintroduced to the market in 2002 with a few caveats, including a narrower indication.		Jul 1, 2004	1056
Manufacturer halts shipments of nefazodone: Bristol-Myers Squibb says the move is based on declining sales--not reports of liver toxicity.		Jun 1, 2004	584
Second IM atypical is approved for agitation.		May 1, 2004	393
FDA panel backs facial filler for HIV lipoatrophy.		May 1, 2004	1699
Public should know OTC analgesics' risks.		Apr 1, 2004	798
FDA experts vote in favor of OTC sale of Plan B.		Apr 1, 2004	1056
Psychiatric adverse events reported to FDA.		Mar 1, 2004	578
FDA panel backs warning on kids, antidepressants; goal is to raise awareness about possible suicide risks before definitive review.		Feb 1, 2004	848
Olanzapine-fluoxetine combo wins approval: drug tx is a first for bipolar depression.		Feb 1, 2004	1291
FDA approves quetiapine for acute bipolar mania.		Feb 1, 2004	367